Editing Muscle-invasive Bladder Cancer (2017) (section)

== Questions ==

# As per the 2017 AUA MIBC Guidelines, what are the contraindications to cisplatin-based NAC? Do these differ from the CUA MIBC Guidelines? What the second-line NAC regimen for those with contraindications to cisplatin-based NAC?
# As per the 2017 AUA MIBC Guidelines, what is the timing of cystectomy with regard to completion of chemotherapy?
# As per the 2017 AUA MIBC Guidelines, who should receive adjuvant chemotherapy after RC?
# At the time of RC, which organs are removed with the bladder?
# As per the 2017 AUA MIBC Guidelines, what are the indications for a urethrectomy in patients undergoing RC?
# As per the 2017 AUA MIBC Guidelines, what are the contraindications to a continent diversion?
# As per the 2017 AUA MIBC Guidelines, which lymph nodes should be removed at the time of RC?
# As per the 2017 AUA MIBC Guidelines, what are the ideal characteristics for bladder preservation in the treatment of MIBC? What is the recommended bladder preservation treatment method?
# As per the 2017 AUA MIBC Guidelines, what is the role of partial cystectomy in the treatment of MIBC and which patients are candidates?
# As per the 2017 AUA MIBC Guidelines, what are the recommended laboratory investigations during follow-up of RC?